Abbreviations
- DVT:
-
Deep vein thrombosis
- LFT:
-
Liver function test
- ALT:
-
Alanine aminotransferase
- ULN:
-
Upper limit of normal
- AST:
-
Aspartate aminotransferase
- GGT:
-
Gamma-glutamyltransferase
- ALP:
-
Alkaline phosphatase
- INR:
-
International normalised ratio
- DILI:
-
Drug-induced liver injury
- CYP:
-
Cytochrome P450
References
Harder S, Graff J (2013) Novel oral anticoagulants: clinical pharmacology, indications and practical considerations. Eur J Clin Pharmacol 69:1617–1633
Caldeira D, Barra M, Santos AT, de Abreu D, Pinto FJ, Ferreira JJ, Costa J (2014) Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis. Heart 100:550–556
Liakoni E, Rätz Bravo AE, Terracciano L, Heim M, Krahenbuhl S (2014) Symptomatic hepatocellular liver injury with hyperbilirubinemia in two patients treated with rivaroxaban. JAMA Intern Med 174:1683–1686
Russman S, Niedrig DF, Budmiger M, Schmidt C, Stiger B, Hurlimann S et al (2014) Rvaroxaban postmarketing risk of liver injury. J Hepatol 61:293–300
Author information
Authors and Affiliations
Contributions
All of the above listed authors participated meaningfully in this study and have seen and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest..
Informed consent
Informed consent was obtained from the patient prior to publication of this report.
Rights and permissions
About this article
Cite this article
Peverelle, M., Asadi, K. & Sinclair, M. Drug-induced liver failure due to rivaroxaban. Ann Hematol 97, 2267–2268 (2018). https://doi.org/10.1007/s00277-018-3364-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-018-3364-z